Skip to content

Dr. Sofie Van de Velde – Van De Ginste BV

Active
Private limited companyfounded 2020active for 6 yearsMoerstraat(HOM) 7, 2811 Mechelen, BelgiumKBO/BCE: BE 0757.695.110
Summary

Dr. Sofie Van de Velde – Van De Ginste BV has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €40,880 and a net result of €335,880. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 16% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Dr. Sofie Van de Velde – Van De Ginste BVActiveChecked score 94/100

Overview

Official details

Source: KBO
Status
Active since 31-10-2020 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.309.282.859 2811 Mechelen, since 31-10-2020
Financial year end
31 December
Peppol
Reachable since 24-11-2023

Board and ownership

Board
  • Van de Velde - Van De ginste SofieDirector

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€443,918
▲ 119%
Turnover
≈ €690,000
estimated
Profit
€335,880
▲ 127%
Equity
€40,880
▲ 718%
Total assets
€298,325
▲ 25.2%
Score breakdownraises riskEquity €40,880 (13.7% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €298,325Figures for financial year 2025 (filed on 06-06-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 49% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 39+12
equity 13.7% of total assets
Liquidity 8+3
short-term debt 86.3% · cash 4.8%
Profitability 100=
return on assets 112.6%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026highest value 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.13 (0.98 in 2024), below the usual 1.5. Short-term debt is 86.3% and cash 4.8% of total assets. 86.3% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 16% of them on solvency, 1% on liquidity, 80% on profitability and 99% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €298,325
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 06-06-2026)
NBB · annual accounts
raises risk · Equity €40,880 (13.7% of total assets)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 20706 sector peers (2025).
NBB · sector comparison
Position among 20706 sector peers
Solvency
better than 16%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
56 days early
2024
51 days early
2023
50 days early
2022
52 days early
2021
53 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 52 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Result rose in 2025from €147,924 to €335,880 ▲ 127% View
  • Positive: Higher net result than 95% of companies in human healthsector median €60,150 · 20,693 companies €335,880 View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Positive: 5 profitable years in a rowprofit 2025: €335,880 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 10 events

Comparable companies

These companies have the same main activity as Dr. Sofie Van de Velde – Van De Ginste BV: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €295,000 and €352,000, founded between 2019 and 2021.

CompanyTotal assetsGross margin
Dr. Sofie Van de Velde – Van De Ginste BV Mechelen€298,325€443,918
DOKTER T. PILATE Putte€352,169€424,938
Dr. Sara Buys - Anesthesie Affligem€313,167€434,375
DOKTER SARAH ROELS Brugge€295,255€400,961
Dr. NGUYEN Pham Anh Hong, pneumologe Dilbeek€313,202€445,994
Sam Thom Ieper€342,917€415,776
Dr. Pieter-Jan Geerts Kortrijk€307,634€410,082
Full comparison

Key facts about Dr. Sofie Van de Velde – Van De Ginste BV

What is the company number of Dr. Sofie Van de Velde – Van De Ginste BV?
The company number of Dr. Sofie Van de Velde – Van De Ginste BV is 0757.695.110. The VAT number is the same number with BE in front: BE 0757.695.110.
Where is Dr. Sofie Van de Velde – Van De Ginste BV based?
The registered office is at Moerstraat(HOM) 7, 2811 Mechelen.Company details
What does Dr. Sofie Van de Velde – Van De Ginste BV do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Sofie Van de Velde – Van De Ginste BV?
The legal form of Dr. Sofie Van de Velde – Van De Ginste BV is Private limited company (BV).
When was Dr. Sofie Van de Velde – Van De Ginste BV founded?
Dr. Sofie Van de Velde – Van De Ginste BV was founded on 31-10-2020.
Is Dr. Sofie Van de Velde – Van De Ginste BV still active?
Yes, Dr. Sofie Van de Velde – Van De Ginste BV is an active enterprise in the KBO register.
What is the turnover of Dr. Sofie Van de Velde – Van De Ginste BV?
The turnover in financial year 2025 is ≈ €690,000. This figure is estimated from the gross margin of €443,918 and 36 comparable companies (NACE 862). It probably lies between €620,000 and €860,000.Financials
Is Dr. Sofie Van de Velde – Van De Ginste BV profitable?
In financial year 2025, Dr. Sofie Van de Velde – Van De Ginste BV made a profit of €335,880.
Where can I find the annual accounts of Dr. Sofie Van de Velde – Van De Ginste BV?
Dr. Sofie Van de Velde – Van De Ginste BV filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sofie Van de Velde – Van De Ginste BV due?
Dr. Sofie Van de Velde – Van De Ginste BV must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.